semaglutide cheaper alternative Type 2 diabetes: New Ozempic pill now available in the U.S India's weight-loss drugs to get

First non-insulin drug for pediatric use approved in nearly 20 years.

As patients in regions like New York City increasingly seek weight management solutions, it's essential to understand how this medication might affect oral health

Although people appear to regain weight rapidly after taking GLP-1 weight-loss drugs this may plateau after time.

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status

Two compounded orders were approved in five minutes or less

Sciwind filed for an IPO on the Hong Kong Stock Exchange a few months after that Reuters report to help bankroll its sprawling pipeline